# Bambusa Therapeutics

**Canonical:** https://apis.io/providers/bambusa-therapeutics/  
**Website:** https://bambusatx.com/  
**APIs profiled:** 0

Bambusa Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in the Boston Seaport, founded in 2024 by Shanshan Xu and Helmut Jeggle to develop next-generation bispecific antibodies for immunological and inflammatory (I&I) diseases. Its antibody-engineering platform combines half-life extension with high-concentration subcutaneous delivery, and its pipeline spans dermatology, respiratory, gastroenterology and rheumatology — led by BBT-001 (IL-31 x IL-4Ralpha, in a Phase 1b/2a atopic dermatitis trial) and BBT-002 for COPD. The company raised a Series Seed in 2024, an approximately $90M Series A led by RA Capital Management in February 2025, and an oversubscribed Series A-2 in November 2025. It is a therapeutics developer, not a software vendor, and publishes no public API, SDK or developer program.

## Kin Score — 2.9 / 100 (minimal)

Scored 2026-08-19 under rubric 0.12.0. Trend: flat (-2.2 from 5.1).

| Facet | Score |
|---|---|
| Discoverability | 46.3 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Security (1)

- **Bambusa Therapeutics Domain Security** — TLSv1.3 · DNSSEC · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Immunology, Clinical Trials, Drug Development, Antibodies

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/bambusa-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.